Mito-lonidamine, compositions and methods of use
US11352382B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 3, 2019 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | Jan 3, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to mito-lonidamine compounds, compositions and methods of use in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.